SM
XLRN

SG3 Management’s Acceleron Pharma XLRN Stock Holding History

SG3 Management’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-60,000
Closed -$10.3M – 1411
2021
Q3 		$10.3M Buy
+60,000
New +$7.85M 0.31% 57

SG3 Management's XLRN Position: Q4 2021 in Review

SG3 Management sold out of Acceleron Pharma (XLRN) in Q4 2021, closing a stake of 60,000 shares — an estimated $10.3M sold.

SG3 Management first reported a position in XLRN in Q3 2021 and held it in 1 quarter. The position peaked at $10.3M in Q3 2021. 1 fund tracked by Wall St. Rank holds XLRN as of Q4 2021.

  • SG3 Management reported no remaining Acceleron Pharma position as of Q4 2021 after selling out during the quarter.
  • SG3 Management sold 60,000 Acceleron Pharma shares in Q4 2021, an estimated $10.3M.
  • SG3 Management first reported a position in Acceleron Pharma in Q3 2021 and held it in 1 quarter.
  • SG3 Management's Acceleron Pharma position peaked at $10.3M in Q3 2021.
  • 1 fund tracked by Wall St. Rank held Acceleron Pharma as of Q4 2021.

Based on SG3 Management's 13F filing for Q4 2021, filed 15 Feb 2022.